{"transactions":[{"id":708026,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T20:43:59.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":276,"price":74.36,"value":20523.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 276 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $20,568.49 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $74.36, which was the closing price per share of the Company's common stock on July 15, 2026. The awards will vest immediately upon grant date."}],"balance_after":42978,"source":{"system":"sec-edgar","filing":"0001628280-26-048488","document":"wk-form4_1784234637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828026048488/wk-form4_1784234637.xml","form_type":"4"}},{"id":730449,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:30:22.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":5491,"price":63.74,"value":349996.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 5,491 deferred stock units (\"DSUs\") granted to Mr. Chase under our 2024 Equity Incentive Plan in lieu of 5,491 restricted stock units. The DSUs will vest in full on the earlier to occur of (i) June 18, 2027 and (ii) the date of the next annual meeting of the Company's stockholders, in each case subject to continued service through the applicable vesting date. Each DSU represents the right to receive, at settlement, one share of common stock."}],"balance_after":42702,"source":{"system":"sec-edgar","filing":"0001628280-26-044736","document":"wk-form4_1782163820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828026044736/wk-form4_1782163820.xml","form_type":"4"}},{"id":743096,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T23:00:39.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":13300,"derivative":{"exercise_price":12.89,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001563572-26-000001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000156357226000001/ownership.xml","form_type":"4"}},{"id":743095,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T23:00:39.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":143893,"source":{"system":"sec-edgar","filing":"0001563572-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000156357226000001/ownership.xml","form_type":"4"}},{"id":805609,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T20:07:03.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":408,"price":49.79,"value":20314.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 408 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Incentive Award Plan in lieu of $20,342.47 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $49.79, which was the closing price per share of the Company's common stock on April 15, 2026. The awards will vest immediately upon grant date."}],"balance_after":37211,"source":{"system":"sec-edgar","filing":"0001628280-26-025730","document":"wk-form4_1776456421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828026025730/wk-form4_1776456421.xml","form_type":"4"}},{"id":937146,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T21:58:25.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":213,"price":97.44,"value":20754.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 213 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Incentive Award Plan in lieu of $20,794.52 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $97.44, which was the closing price per share of the Company's common stock on January 15, 2026. The awards will vest immediately upon grant date."}],"balance_after":36803,"source":{"system":"sec-edgar","filing":"0001628280-26-002435","document":"wk-form4_1768600702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828026002435/wk-form4_1768600702.xml","form_type":"4"}},{"id":1017578,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T22:17:37.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":275,"price":75.52,"value":20768.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 275 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $20,794.52 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $75.52, which was the closing price per share of the Company's common stock on October 15, 2025. The awards will vest immediately upon grant date."}],"balance_after":36590,"source":{"system":"sec-edgar","filing":"0001628280-25-045265","document":"wk-form4_1760653055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828025045265/wk-form4_1760653055.xml","form_type":"4"}},{"id":1057810,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-22T20:30:14.000Z","date":"2025-08-20","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":10.03,"value":1003000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on August 20, 2025 at each separate price."}],"balance_after":134693,"source":{"system":"sec-edgar","filing":"0000950170-25-110979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025110979/ownership.xml","form_type":"4"}},{"id":1085512,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-17T21:47:43.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":533,"price":38.53,"value":20536.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 533 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $20,568.49 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $38.53, which was the closing price per share of the Company's common stock on July 15, 2025. The awards will vest immediately upon grant date."}],"balance_after":36315,"source":{"system":"sec-edgar","filing":"0001699031-25-000158","document":"wk-form4_1752788856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000169903125000158/wk-form4_1752788856.xml","form_type":"4"}},{"id":1111605,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:25:02.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11450,"derivative":{"exercise_price":8.37,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11450},"source":{"system":"sec-edgar","filing":"0000950170-25-086231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086231/ownership.xml","form_type":"4"}},{"id":1111604,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:25:02.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":34693,"source":{"system":"sec-edgar","filing":"0000950170-25-086231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025086231/ownership.xml","form_type":"4"}},{"id":1129205,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T23:23:43.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6082,"price":41.1,"value":249970.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 6,082 restricted stock units (\"RSUs\") granted to Mr. Chase under our 2024 Equity Incentive Plan. The RSUs will vest in full on the earlier to occur of (i) May 29, 2026 and (ii) the date of the next annual meeting of the Company's stockholders, in each case subject to continued service through the applicable vesting date. Each RSU represents the right to receive, at settlement, one share of common stock."}],"balance_after":35782,"source":{"system":"sec-edgar","filing":"0001699031-25-000129","document":"wk-form4_1748647406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000169903125000129/wk-form4_1748647406.xml","form_type":"4"}},{"id":1170982,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T22:34:35.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":784,"price":25.94,"value":20336.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 784 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $20,342.47 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $25.94, which was the closing price per share of the Company's common stock on April 15, 2025. The awards will vest immediately upon grant date."}],"balance_after":29700,"source":{"system":"sec-edgar","filing":"0001699031-25-000084","document":"wk-form4_1744842868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000169903125000084/wk-form4_1744842868.xml","form_type":"4"}},{"id":1301499,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-16T21:53:42.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":1182,"price":17.58,"value":20779.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,182 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $20,794.52 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $17.58, which was the closing price per share of the Company's common stock on January 15, 2025. The awards will vest immediately upon grant date."}],"balance_after":28916,"source":{"system":"sec-edgar","filing":"0001628280-25-001746","document":"wk-form4_1737064416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828025001746/wk-form4_1737064416.xml","form_type":"4"}},{"id":1378180,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-01T22:17:12.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":210,"price":13.62,"value":2860.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 210 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $2,863.01 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $13.62, which was the closing price per share of the Company's common stock on October 30, 2024. The awards will vest immediately upon grant date."}],"balance_after":27734,"source":{"system":"sec-edgar","filing":"0001628280-24-044798","document":"wk-form4_1730499426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828024044798/wk-form4_1730499426.xml","form_type":"4"}},{"id":1384777,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T22:33:47.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":1054,"price":14.01,"value":14766.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,054 deferred stock units granted to Mr. Chase under our deferred stock program and 2024 Equity Incentive Plan in lieu of $14,767.12 of cash fees payable to Mr. Chase for his service as a director, based on a price per share of $14.01, which was the closing price per share of the Company's common stock on October 15, 2024. The awards will vest immediately upon grant date."}],"balance_after":27524,"source":{"system":"sec-edgar","filing":"0001628280-24-043071","document":"wk-form4_1729204421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828024043071/wk-form4_1729204421.xml","form_type":"4"}},{"id":1468103,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-27T21:14:17.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":26470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 26,470 restricted stock units (\"RSUs\") which will vest and become payable in three substantially equal annual installments beginning on June 21, 2025, subject to full accelerated vesting upon a change in control of the Issuer. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs will be settled in common stock upon vesting."}],"balance_after":26470,"source":{"system":"sec-edgar","filing":"0001628280-24-030363","document":"wk-form4_1719522849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000162828024030363/wk-form4_1719522849.xml","form_type":"4"}},{"id":1478956,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:16:41.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":11515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":11515,"derivative":{"exercise_price":25.85,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":11515},"source":{"system":"sec-edgar","filing":"0000950170-24-073680","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073680/ownership.xml","form_type":"4"}},{"id":1478955,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:16:41.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":7737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":26693,"source":{"system":"sec-edgar","filing":"0000950170-24-073680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024073680/ownership.xml","form_type":"4"}},{"id":1852200,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:30:18.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2023 with respect to 2,447 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":2447,"derivative":{"exercise_price":45.2,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":2447},"source":{"system":"sec-edgar","filing":"0001209191-23-037910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037910/doc4.xml","form_type":"4"}},{"id":1852199,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:30:18.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":18956,"source":{"system":"sec-edgar","filing":"0001209191-23-037910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037910/doc4.xml","form_type":"4"}},{"id":1918082,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T21:04:44.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":14931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 14, 2023 with respect to 14,931 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on April 14, 2024 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter."}],"balance_after":14931,"derivative":{"exercise_price":38.16,"expiration_date":"2033-04-13","underlying":"Common Stock","underlying_shares":14931},"source":{"system":"sec-edgar","filing":"0000899243-23-011381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000089924323011381/doc4.xml","form_type":"4"}},{"id":1918081,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T21:04:44.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":10483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":17283,"source":{"system":"sec-edgar","filing":"0000899243-23-011381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000089924323011381/doc4.xml","form_type":"4"}},{"id":115664,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-06-28T20:47:58.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":30400,"price":67.3,"value":2045920.0,"ownership":{"direct":true},"balance_after":169552,"source":{"system":"sec-edgar","filing":"0001179110-19-008215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019008215/edgar.xml","form_type":"4"}},{"id":118973,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common stock, $0.01 par value","published_at":"2019-03-04T21:54:02.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":27276,"price":79.41,"value":2165987.16,"ownership":{"direct":true},"balance_after":139152,"source":{"system":"sec-edgar","filing":"0001179110-19-003074","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019003074/edgar.xml","form_type":"4"}},{"id":119470,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Option (right to buy)","published_at":"2019-02-22T22:20:53.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":60747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,249 on February 21, 2020, 20,249 on February 21, 2021, and 20,249 on February 21, 2022."}],"balance_after":60747,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":60747},"source":{"system":"sec-edgar","filing":"0001179110-19-002371","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019002371/edgar.xml","form_type":"4"}},{"id":119469,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-02-22T22:20:53.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":8481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":166428,"source":{"system":"sec-edgar","filing":"0001179110-19-002371","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019002371/edgar.xml","form_type":"4"}},{"id":119468,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-02-22T22:20:53.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":14989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":157947,"source":{"system":"sec-edgar","filing":"0001179110-19-002371","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019002371/edgar.xml","form_type":"4"}},{"id":119467,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-02-22T22:20:53.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":15945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":142958,"source":{"system":"sec-edgar","filing":"0001179110-19-002371","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019002371/edgar.xml","form_type":"4"}},{"id":119466,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-02-22T22:20:53.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":22150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":127013,"source":{"system":"sec-edgar","filing":"0001179110-19-002371","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911019002371/edgar.xml","form_type":"4"}},{"id":121836,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & Administration"}}],"security":"Common Stock, $0.01 par value","published_at":"2018-12-14T22:12:45.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":60000,"price":90,"value":5400000.0,"ownership":{"direct":true},"balance_after":104863,"source":{"system":"sec-edgar","filing":"0001179110-18-013893","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018013893/edgar.xml","form_type":"4"}},{"id":131362,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2018-03-02T22:28:59.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":24.2082,"exercise_date":"2014-02-17","expiration_date":"2021-02-17","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131361,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2018-03-02T22:28:59.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":28.3122,"exercise_date":"2013-02-19","expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":13400},"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131360,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:28:59.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":32400,"price":114.4965,"value":3709686.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.27 to $114.67, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":164863,"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131359,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:28:59.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":19000,"price":24.2082,"value":459955.8,"ownership":{"direct":true},"balance_after":197263,"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131358,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:28:59.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":13400,"price":28.3122,"value":379383.48,"ownership":{"direct":true},"balance_after":178263,"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131357,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:28:59.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":38528,"price":119.4444,"value":4601953.8432,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.32 to $119.54, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":164863,"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":131356,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:28:59.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":28407,"price":118.26,"value":3359411.82,"ownership":{"direct":true},"balance_after":203391,"source":{"system":"sec-edgar","filing":"0001179110-18-003333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018003333/edgar.xml","form_type":"4"}},{"id":132298,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2018-02-16T22:59:30.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":45840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 15,280 on February 15, 2019, 15,280 on February 15, 2020, and 15,280 on February 15, 2021."}],"balance_after":45840,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":45840},"source":{"system":"sec-edgar","filing":"0001179110-18-002305","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018002305/edgar.xml","form_type":"4"}},{"id":132297,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:59:30.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":14991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":231798,"source":{"system":"sec-edgar","filing":"0001179110-18-002305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018002305/edgar.xml","form_type":"4"}},{"id":132296,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:59:30.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":17319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":216807,"source":{"system":"sec-edgar","filing":"0001179110-18-002305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018002305/edgar.xml","form_type":"4"}},{"id":132295,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:59:30.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":15945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":199488,"source":{"system":"sec-edgar","filing":"0001179110-18-002305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911018002305/edgar.xml","form_type":"4"}},{"id":140370,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2017-05-19T21:01:53.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":28.13,"exercise_date":"2012-02-20","expiration_date":"2019-02-19","underlying":"Common stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0001179110-17-007635","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017007635/edgar.xml","form_type":"4"}},{"id":140369,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2017-05-19T21:01:53.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":28.86,"exercise_date":"2011-02-15","expiration_date":"2018-02-14","underlying":"Common stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001179110-17-007635","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017007635/edgar.xml","form_type":"4"}},{"id":140368,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-05-19T21:01:53.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":38300,"price":65.35,"value":2502905.0,"ownership":{"direct":true},"balance_after":183543,"source":{"system":"sec-edgar","filing":"0001179110-17-007635","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017007635/edgar.xml","form_type":"4"}},{"id":140367,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-05-19T21:01:53.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":12800,"price":28.13,"value":360064.0,"ownership":{"direct":true},"balance_after":221843,"source":{"system":"sec-edgar","filing":"0001179110-17-007635","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017007635/edgar.xml","form_type":"4"}},{"id":140366,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-05-19T21:01:53.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":25500,"price":28.86,"value":735930.0,"ownership":{"direct":true},"balance_after":209043,"source":{"system":"sec-edgar","filing":"0001179110-17-007635","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017007635/edgar.xml","form_type":"4"}},{"id":142498,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-03-02T23:11:11.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":40212,"price":62.22,"value":2501990.64,"ownership":{"direct":true},"balance_after":183543,"source":{"system":"sec-edgar","filing":"0001179110-17-003700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017003700/edgar.xml","form_type":"4"}},{"id":143040,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2017-02-21T22:50:30.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 33,367 on 02/16/2018, 33,366 on 02/16/2019, and 33,367 on 02/16/2020."}],"balance_after":100100,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common stock","underlying_shares":100100},"source":{"system":"sec-edgar","filing":"0001179110-17-002805","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017002805/edgar.xml","form_type":"4"}},{"id":143039,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:50:30.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":15945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":223755,"source":{"system":"sec-edgar","filing":"0001179110-17-002805","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017002805/edgar.xml","form_type":"4"}},{"id":143038,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:50:30.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":35440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":207810,"source":{"system":"sec-edgar","filing":"0001179110-17-002805","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911017002805/edgar.xml","form_type":"4"}},{"id":146035,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2016-12-02T22:08:18.000Z","date":"2016-12-02","kind":"exercise","acquired":false,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":27.29,"exercise_date":"2010-02-16","expiration_date":"2017-02-15","underlying":"Common stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0001179110-16-032340","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911016032340/edgar.xml","form_type":"4"}},{"id":146034,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2016-12-02T22:08:18.000Z","date":"2016-12-02","kind":"sale","acquired":false,"shares":6600,"price":59.19,"value":390654.0,"ownership":{"direct":true},"balance_after":172370,"source":{"system":"sec-edgar","filing":"0001179110-16-032340","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911016032340/edgar.xml","form_type":"4"}},{"id":146033,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2016-12-02T22:08:18.000Z","date":"2016-12-02","kind":"exercise","acquired":true,"shares":6600,"price":27.29,"value":180114.0,"ownership":{"direct":true},"balance_after":178970,"source":{"system":"sec-edgar","filing":"0001179110-16-032340","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911016032340/edgar.xml","form_type":"4"}},{"id":155266,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2016-03-02T22:19:50.000Z","date":"2016-02-29","kind":"tax_withholding","acquired":false,"shares":45658,"price":56,"value":2556848.0,"ownership":{"direct":true},"balance_after":172370,"source":{"system":"sec-edgar","filing":"0001179110-16-020677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911016020677/edgar.xml","form_type":"4"}},{"id":155726,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2016-02-22T22:06:06.000Z","date":"2016-02-18","kind":"grant","acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 31,800 on 02/18/2017, 31,800 on 02/18/2018, and 31,800 on 02/18/2019."}],"balance_after":95400,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001179110-16-019778","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911016019778/edgar.xml","form_type":"4"}},{"id":166098,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2015-03-03T23:05:08.000Z","date":"2015-02-28","kind":"tax_withholding","acquired":false,"shares":8192,"price":60.5,"value":495616.0,"ownership":{"direct":true},"balance_after":218028,"source":{"system":"sec-edgar","filing":"0001179110-15-004094","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911015004094/edgar.xml","form_type":"4"}},{"id":166097,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2015-03-03T23:05:08.000Z","date":"2015-02-27","kind":"tax_withholding","acquired":false,"shares":10299,"price":60.52,"value":623295.48,"ownership":{"direct":true},"balance_after":226220,"source":{"system":"sec-edgar","filing":"0001179110-15-004094","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911015004094/edgar.xml","form_type":"4"}},{"id":166352,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2015-02-23T22:08:40.000Z","date":"2015-02-19","kind":"grant","acquired":true,"shares":110770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 36,924 on 02/19/2016, 36,923 on 02/19/2017, and 36,923 on 02/18/2018"}],"balance_after":110770,"derivative":{"exercise_price":58.88,"exercise_date":"2016-02-19","expiration_date":"2025-02-18","underlying":"Common stock","underlying_shares":110770},"source":{"system":"sec-edgar","filing":"0001179110-15-003161","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911015003161/edgar.xml","form_type":"4"}},{"id":166351,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2015-02-23T22:08:40.000Z","date":"2015-02-19","kind":"grant","acquired":true,"shares":56040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned by the reporting person includes an additional 411 shares of AbbVie stock."}],"balance_after":236519,"source":{"system":"sec-edgar","filing":"0001179110-15-003161","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911015003161/edgar.xml","form_type":"4"}},{"id":168238,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2014-12-22T22:22:44.000Z","date":"2014-12-22","kind":"exercise","acquired":false,"shares":8495,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":24.0731,"exercise_date":"2008-02-18","expiration_date":"2015-02-17","underlying":"Common stock","underlying_shares":8495},"source":{"system":"sec-edgar","filing":"0001179110-14-018635","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014018635/edgar.xml","form_type":"4"}},{"id":168237,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-12-22T22:22:44.000Z","date":"2014-12-22","kind":"sale","acquired":false,"shares":8495,"price":68,"value":577660.0,"ownership":{"direct":true},"balance_after":180068,"source":{"system":"sec-edgar","filing":"0001179110-14-018635","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014018635/edgar.xml","form_type":"4"}},{"id":168236,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-12-22T22:22:44.000Z","date":"2014-12-22","kind":"exercise","acquired":true,"shares":8495,"price":24.0731,"value":204500.9845,"ownership":{"direct":true},"balance_after":188563,"source":{"system":"sec-edgar","filing":"0001179110-14-018635","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014018635/edgar.xml","form_type":"4"}},{"id":175697,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-03-04T22:12:14.000Z","date":"2014-03-03","kind":"sale","acquired":false,"shares":100,"price":51.195,"value":5119.5,"ownership":{"direct":true},"balance_after":180068,"source":{"system":"sec-edgar","filing":"0001179110-14-004329","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014004329/edgar.xml","form_type":"4"}},{"id":175696,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-03-04T22:12:14.000Z","date":"2014-03-03","kind":"sale","acquired":false,"shares":1400,"price":50.194,"value":70271.6,"ownership":{"direct":true},"balance_after":180168,"source":{"system":"sec-edgar","filing":"0001179110-14-004329","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014004329/edgar.xml","form_type":"4"}},{"id":175695,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-03-04T22:12:14.000Z","date":"2014-03-03","kind":"sale","acquired":false,"shares":2448,"price":50.191,"value":122867.568,"ownership":{"direct":true},"balance_after":181568,"source":{"system":"sec-edgar","filing":"0001179110-14-004329","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014004329/edgar.xml","form_type":"4"}},{"id":175694,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-03-04T22:12:14.000Z","date":"2014-02-28","kind":"tax_withholding","acquired":false,"shares":9873,"price":51.91,"value":512507.43,"ownership":{"direct":true},"balance_after":184016,"source":{"system":"sec-edgar","filing":"0001179110-14-004329","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014004329/edgar.xml","form_type":"4"}},{"id":176031,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2014-02-24T22:06:53.000Z","date":"2014-02-20","kind":"grant","acquired":true,"shares":92740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 30,914 on 02/20/2015, 30,913 on 02/20/2016, and 30,913 on 02/20/2017."}],"balance_after":92740,"derivative":{"exercise_price":51.42,"exercise_date":"2015-02-20","expiration_date":"2024-02-19","underlying":"Common stock","underlying_shares":92740},"source":{"system":"sec-edgar","filing":"0001179110-14-003467","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014003467/edgar.xml","form_type":"4"}},{"id":176030,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2014-02-24T22:06:53.000Z","date":"2014-02-20","kind":"grant","acquired":true,"shares":53770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":193889,"source":{"system":"sec-edgar","filing":"0001179110-14-003467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911014003467/edgar.xml","form_type":"4"}},{"id":178143,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":false,"shares":3438,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.985,"exercise_date":"2013-03-15","expiration_date":"2014-02-19","underlying":"Common stock","underlying_shares":3438},"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178142,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":false,"shares":1591,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.2421,"exercise_date":"2013-03-14","expiration_date":"2014-02-19","underlying":"Common stock","underlying_shares":1591},"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178141,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":false,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":34.4889,"exercise_date":"2013-01-31","expiration_date":"2014-02-19","underlying":"Common stock","underlying_shares":1620},"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178140,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":false,"shares":963,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":28.9667,"exercise_date":"2007-09-30","expiration_date":"2014-02-19","underlying":"Common stock","underlying_shares":963},"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178139,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"tax_withholding","acquired":false,"shares":6149,"price":54.32,"value":334013.68,"ownership":{"direct":true},"balance_after":140119,"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178138,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":true,"shares":3438,"price":35.985,"value":123716.43,"ownership":{"direct":true},"balance_after":146268,"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178137,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":true,"shares":1591,"price":35.2421,"value":56070.1811,"ownership":{"direct":true},"balance_after":142830,"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178136,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":true,"shares":1620,"price":34.4889,"value":55872.018,"ownership":{"direct":true},"balance_after":141239,"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":178135,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-12-21T01:32:30.000Z","date":"2013-12-19","kind":"exercise","acquired":true,"shares":963,"price":28.9667,"value":27894.9321,"ownership":{"direct":true},"balance_after":139619,"source":{"system":"sec-edgar","filing":"0001179110-13-018461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013018461/edgar.xml","form_type":"4"}},{"id":186443,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-03-04T22:09:08.000Z","date":"2013-02-28","kind":"tax_withholding","acquired":false,"shares":5260,"price":36.73,"value":193199.8,"ownership":{"direct":true},"balance_after":138656,"source":{"system":"sec-edgar","filing":"0001179110-13-004014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013004014/edgar.xml","form_type":"4"}},{"id":186892,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-02-20T00:06:31.000Z","date":"2013-02-14","kind":"grant","acquired":true,"shares":115830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 38,610 on 02/14/2014, 38,610 on 02/14/2015, and 38,610 on 02/14/2016."}],"balance_after":115830,"derivative":{"exercise_price":35.88,"exercise_date":"2014-02-14","expiration_date":"2023-02-13","underlying":"Common stock","underlying_shares":115830},"source":{"system":"sec-edgar","filing":"0001179110-13-003030","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013003030/edgar.xml","form_type":"4"}},{"id":186891,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-02-20T00:06:31.000Z","date":"2013-02-19","kind":"tax_withholding","acquired":false,"shares":2912,"price":37.58,"value":109432.96,"ownership":{"direct":true},"balance_after":143916,"source":{"system":"sec-edgar","filing":"0001179110-13-003030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013003030/edgar.xml","form_type":"4"}},{"id":186890,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-02-20T00:06:31.000Z","date":"2013-02-14","kind":"grant","acquired":true,"shares":56700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":146828,"source":{"system":"sec-edgar","filing":"0001179110-13-003030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013003030/edgar.xml","form_type":"4"}},{"id":187219,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-02-08T22:04:18.000Z","date":"2013-02-07","kind":"exercise","acquired":false,"shares":2177,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.4265,"exercise_date":"2012-11-26","expiration_date":"2013-02-13","underlying":"Common stock","underlying_shares":2177},"source":{"system":"sec-edgar","filing":"0001179110-13-002287","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013002287/edgar.xml","form_type":"4"}},{"id":187218,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2013-02-08T22:04:18.000Z","date":"2013-02-07","kind":"exercise","acquired":false,"shares":2390,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.0005,"exercise_date":"2012-10-27","expiration_date":"2013-02-13","underlying":"Common stock","underlying_shares":2390},"source":{"system":"sec-edgar","filing":"0001179110-13-002287","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013002287/edgar.xml","form_type":"4"}},{"id":187217,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-02-08T22:04:18.000Z","date":"2013-02-07","kind":"tax_withholding","acquired":false,"shares":4188,"price":37.14,"value":155542.32,"ownership":{"direct":true},"balance_after":90128,"source":{"system":"sec-edgar","filing":"0001179110-13-002287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013002287/edgar.xml","form_type":"4"}},{"id":187216,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-02-08T22:04:18.000Z","date":"2013-02-07","kind":"exercise","acquired":true,"shares":2177,"price":32.4265,"value":70592.4905,"ownership":{"direct":true},"balance_after":94316,"source":{"system":"sec-edgar","filing":"0001179110-13-002287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013002287/edgar.xml","form_type":"4"}},{"id":187215,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11965,"kind":"person","name":"CHASE WILLIAM J","position":1,"cik":"0001563572","reported_name":"CHASE WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common stock, $0.01 par value","published_at":"2013-02-08T22:04:18.000Z","date":"2013-02-07","kind":"exercise","acquired":true,"shares":2390,"price":32.0005,"value":76481.195,"ownership":{"direct":true},"balance_after":92139,"source":{"system":"sec-edgar","filing":"0001179110-13-002287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563572/000117911013002287/edgar.xml","form_type":"4"}}]}